Gliomatosis cerebri evaluated by 18Fα-methyl tyrosine positron-emission tomography

Neuroradiology

Volumn 45, Issue 10, 2003, Pages 700-707

  Sato, Noriko ^a   Inoue, T ^b   Tomiyoshi, K ^a   Aoki, J ^a   Oriuchi, N ^a   Takahashi, A ^a   Otani, T ^a   Kurihara, H ^a   Sasaki, T ^a   Endo, K ^a  

^a GUNMA UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Fluorodeoxyglucose; Gliomatosis cerebri; L 3 18F methyl tyrosine; Magnetic resonance imaging; Positron emission tomography

Indexed keywords

CARBON 11; FLUORINE 18; FLUORODEOXYGLUCOSE; FLUORODEOXYGLUCOSE F 18; IODINE 123; METHIONINE C 11; METIROSINE; TRACER;

ADOLESCENT; ADULT; ARTICLE; BRAIN CORTEX; BRAIN DISEASE; CANCER INFILTRATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG HALF LIFE; DRUG UPTAKE; FEMALE; GLIOMA; GLIOSIS; HUMAN; IMAGE ANALYSIS; INTRACRANIAL HYPERTENSION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIODIAGNOSIS; STATISTICAL ANALYSIS;

ADULT; AGED; ALPHA-METHYLTYROSINE; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASMS, NEUROEPITHELIAL; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0242657295     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00234-003-1057-2     Document Type: Article

References (40)

1. Bebin J, Tytus JS (1956) Gliomatosis cerebri-case report. Neurology 6: 815-822
2. Couch JR, Weiss SA (1974) Gliomatosis cerebri. Reports of four cases and review of the literatures. Neurology 24: 504-511
3. Dunn J Jr, Kernohan JW (1956) Gliomatosis cerebri. Arch Pathol 64: 82-91
4. Artigas J, Cervos-Navarro J, Iglesias JR, Ebhardt G (1985) Gliomatosis cerebri: clinical and histological findings. Review article. Clin Neuropathol 4: 135-148
5. Dickson DW, Horoupian DS, Thal LJ, Lantos G (1988) Gliomatosis cerebri presenting with hydrocephalus and dementia. AJNR 9: 200-202
6. Malamud N, Wise BL, Jones OW Jr (1952) Gliomatosis cerebri. J Neurosurg 9: 409-417
7. Kleihues P, Burger PC, Scheihauer BW (1993) The new WHO classification of brain tumors. Brain Pathol 3: 255-268
8. Lantos PL, Bruner JM (2000) Gliomatosis cerebri. In: Kleihues P, Cavenee WK (eds) WHO classification. Tumours of the nervous system. IARC Press, Lyon, pp 92-93
9. Geremia GK, Wollman R, Foust R (1988) Computed tomography of gliomatosis cerebri-case report. J Comput Assist Tomogr 12: 698-701
10. Gottesman M, Laufer H, Patel M (1991) Gliomatosis cerebri: a case report. Clin Neuropathol 10: 303-305
11. 18F] fluorodeoxyglucose and positron emission tomography. Neurology 32: 1323-1329
12. Dexter MA, Parker GD, Besser M, Ell J, Fulham MJ (1995) MR and positron emission tomography with fludeoxyglucose F 18 in gliomatosis cerebri. AJNR 16: 1507-1510
13. Felsberg GJ, Silver SA, Brown MT, Tien RD (1994) Gliomatosis cerebri: radiologic pathologic correlation. AJNR 15: 1745-1753
14. Shin YM, Chang KH, Han MH, et al (1993) Gliomatosis cerebri: comparison of MR and CT features. Am J Roentgenol 161: 859-862
15. Ogawa T, Shishido F, Kanno I, et al (1993) Cerebral glioma: evaluation with methionine PET. Radiology 186: 45-53
16. 18F-alpha-methyl tyrosine using separation and purification system. Nucl Med Commun 18: 169-175
17. 18F-α-methyl tyrosine PET studies in patients with brain tumors. J Nucl Med 40: 399-405
18. Inoue T, Koyama K, Oriuchi N, et al (2001) Detection of malignant tumors: Whole-body PET with fluorine 18α-methyl tyrosine versus FDG-preliminary study. Radiology 220: 54-62
19. 124IMT, and first clinical results. J Nucl Med 31: 281-286
20. 123I]iodo-α-methyl tyrosine: Comparison with natural L-amino acids. J Nucl Med 32: 1225-1228
21. 18F)fluoro- α-methyl tyrosine: A potential tumor-detecting agent. J Nucl Med 39: 663-667
22. Amano S, Inoue T, Tomiyoshi K, et al (1998) In vivo comparison of radiopharmaceuticals in detecting breast cancer. J Nucl Med 39: 1424-1427
23. Meikle SR, Bailey DL, Hooper PK, et al (1995) Simultaneous emission and transmission measurement for attenuation correction in whole-body PET. J Nucl Med 36: 1680-1688
24. Nevin S (1938) Gliomatosis cerebri. Brain 61: 170-191
25. Spagnoli M, Grossman RI, Packer RJ, et al (1987) Magnetic resonance imaging determination of gliomatosis cerebri. Neuroradiology 29: 15-18
26. Souba WW, Pacitti AJ (1992) How amino acids get into cells: mechanisms, models, menus, and mediators. J Parenter Enteral Nutr 16: 569-578
27. 11C]-tyrosine PET for visualization and quantitation of the protein synthesis rate. Radiology 197: 221-226
28. 18F]fluorotyrosine: a new PET tracer of protein synthesis. J Nucl Med 30: 1367-1372
29. Kawai K, Fujibayashi Y, Saji H, et al (1991) A strategy for the study of cerebral amino acid transport using iodine-123-labeled amino acid radiopharmaceutical: 3-iodoalpha-methyl-L-tyrosine. J Nucl Med 32: 819-824
30. 123I-3-iodo-α-methyl-L-tyrosine and preliminary kinetic analysis. Ann Nucl Med 9: 47-50
31. 11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET. J Nucl Med 38: 517-522
32. Kaschten B, Stevenaert A, Sadzot B, et al (1998) Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and /or carbon-11-methionine. J Nucl Med 39: 778-785
33. Delbeke D, Meyerowitz C, Lapidus RL, et al (1995) Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology 195: 47-52
34. Oriuchi N, Tamura M, Shibazaki T, et al (1993) Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis an proliferative activities. J Nucl Med 34: 2087-2089
35. 11C-L-methionine position emission tomography. J Med Imaging 3: 192-196
36. Shintani S, Tsuruoka S, Shiigai T (2000) Serial positron emission tomography (PET) in gliomatosis cerebri treated with radiotherapy: a case report. J Neurol Sci 173: 25-31
37. Mosskin M, Ericson K, Hindmarsh T, et al (1989) Positron emission tomography compared with magnetic resonance imaging and computed tomography in supratentorial gliomas using multiple stereotactic biopsies as reference. Acta Radiol 30: 225-232
38. Brock CS, Meikle SR, Price P (1997) Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology? Eur J Nucl Med 24: 691-705
39. Rise IR, Risoe C, Kirkeby OJ (1998) Cerebrovascular effects of high intracranial pressure after moderate hemorrhage. J Neurosurg Anesthesiol 10: 224-230
40. De Bray JM, Le Jeune JJ, Pourcelot L, Saumet JL, Jallet P (1994) 99mTc-HMPAO cerebral scintigraphy and transcranial pulsed Doppler in acute intracranial hypertension in rabbits. Br J Radiol 67: 540-545